4
|
Mehnert A, Brähler E, Faller H, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Sommerfeldt S, Szalai C, Wittchen HU, Koch U. Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities. J Clin Oncol 2014; 32:3540-6. [DOI: 10.1200/jco.2014.56.0086] [Citation(s) in RCA: 396] [Impact Index Per Article: 39.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
Purpose To provide the 4-week prevalence estimates of mental disorders in cancer populations. Patients and Methods We enrolled adult patients with cancer from in- and outpatient care facilities, using a proportional stratified random sample based on the nationwide cancer incidence in Germany. Patients who scored 9 or above on the Patient Health Questionnaire (PHQ-9) were administered to the standardized computer-assisted Composite International Diagnostic Interview for mental disorders adapted for cancer patients (CIDI-O). A random sample of those with a PHQ-9 score that was less than 9 were selected for a CIDI-O. Results A total of 5,889 patients were identified, which led to 4,020 participants (a 68.3% response rate); of those, 2,141 patients were interviewed. The 4-week total prevalence for any mental disorder was 31.8% (95% CI, 29.8% to 33.8%); this included any anxiety disorder (11.5%; 95% CI, 10.2% to 12.9%), any adjustment disorder (11.1%; 95% CI, 9.7% to 12.4%), any mood disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.2%), nicotine dependence (4.5%; 95% CI, 3.6% to 5.4%), alcohol abuse/dependence (0.3%; 95% CI, 0.1% to 0.6%), any mental disorder resulting from general medical condition (2.3%; 95% CI, 1.7% to 2.9%), and any eating disorder (0%). The highest prevalence for any mental disorder was found in patients with breast cancer (41.6%; 95% CI, 36.8% to 46.4%), followed by patients with head and neck cancer (40.8%; 95% CI, 28.5% to 53.0%). The lowest prevalence was found in patients with pancreatic cancer (20.3%; 95% CI, 8.9% to 31.6%) and stomach/esophagus cancers (21.2%; 95% CI, 12.8% to 29.6%). Conclusion Our findings provide evidence for the strong need for psycho-oncological interventions.
Collapse
Affiliation(s)
- Anja Mehnert
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Elmar Brähler
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Hermann Faller
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Martin Härter
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Monika Keller
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Holger Schulz
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Karl Wegscheider
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Joachim Weis
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Anna Boehncke
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Bianca Hund
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Katrin Reuter
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Matthias Richard
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Susanne Sehner
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Sabine Sommerfeldt
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Carina Szalai
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Hans-Ulrich Wittchen
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| | - Uwe Koch
- Anja Mehnert, Elmar Brähler, Carina Szalai, University Medical Center Leipzig, Leipzig; Anja Mehnert, Martin Härter, Holger Schulz, Karl Wegscheider, Susanne Sehner, Uwe Koch, University Medical Center Hamburg-Eppendorf, Hamburg; Hermann Faller, Matthias Richard, University of Würzburg, Würzburg; Monika Keller, Sabine Sommerfeldt, University Hospital Heidelberg, Heidelberg; Joachim Weis, Anna Boehncke, Tumor Biology Center, University of Freiburg; Bianca Hund, Rhein-Jura-Klinik, Bad Säckingen; Bianca
| |
Collapse
|
7
|
Mehnert A, Koch U, Schulz H, Wegscheider K, Weis J, Faller H, Keller M, Brähler E, Härter M. Prevalence of mental disorders, psychosocial distress and need for psychosocial support in cancer patients - study protocol of an epidemiological multi-center study. BMC Psychiatry 2012; 12:70. [PMID: 22747671 PMCID: PMC3434016 DOI: 10.1186/1471-244x-12-70] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2011] [Accepted: 07/02/2012] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Empirical studies investigating the prevalence of mental disorders and psychological distress in cancer patients have gained increasing importance during recent years, particularly with the objective to develop and implement psychosocial interventions within the cancer care system. Primary purpose of this epidemiological cross-sectional multi-center study is to detect the 4-week-, 12-month-, and lifetime prevalence rates of comorbid mental disorders and to further assess psychological distress and psychosocial support needs in cancer patients across all major tumor entities within the in- and outpatient oncological health care and rehabilitation settings in Germany. METHODS/DESIGN In this multicenter, epidemiological cross-sectional study, cancer patients across all major tumor entities will be enrolled from acute care hospitals, outpatient cancer care facilities, and rehabilitation centers in five major study centers in Germany: Freiburg, Hamburg, Heidelberg, Leipzig and Würzburg. A proportional stratified random sample based on the nationwide incidence of all cancer diagnoses in Germany is used. Patients are consecutively recruited in all centers. On the basis of a depression screener (PHQ-9) 50% of the participants that score below the cutoff point of 9 and all patients scoring above are assessed using the Composite International Diagnostic Interview for Oncology (CIDI-O). In addition, all patients complete validated questionnaires measuring emotional distress, information and psychosocial support needs as well as quality of life. DISCUSSION Epidemiological data on the prevalence of mental disorders and distress provide detailed and valid information for the estimation of the demands for the type and extent of psychosocial support interventions. The data will provide information about specific demographic, functional, cancer- and treatment-related risk factors for mental comorbidity and psychosocial distress, specific supportive care needs and use of psychosocial support offers.
Collapse
Affiliation(s)
- Anja Mehnert
- Department and Outpatient Clinic of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
| | - Uwe Koch
- Department and Outpatient Clinic of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
| | - Holger Schulz
- Department and Outpatient Clinic of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
| | - Karl Wegscheider
- Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - Joachim Weis
- Department of Psychooncology, Tumor Biology Center, University of Freiburg, Breisacher Str. 117, 79106, Freiburg, Germany
| | - Hermann Faller
- Institute of Psychotherapy and Medical Psychology, University of Würzburg, Klinikstr. 3, 97070, Würzburg, Germany
| | - Monika Keller
- Division of Psychooncology, Department for Psychosomatic and General Clinical Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 155, 69120, Heidelberg, Germany
| | - Elmar Brähler
- Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Philipp-Rosenthal-Str. 55, 04103, Leipzig, Germany
| | - Martin Härter
- Department and Outpatient Clinic of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
| |
Collapse
|